THE DUBERSTEIN GROUP INC. for PFIZER INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medical research - Proposed legislation re this issue. Repeal Independent Payment Advisory Board provision of PL 111-148, PL 111-152 - HR 5, Protecting Access to Healthcare Act; HR 452, Medicare Decisions Accountability Act of 2011; S 668, Health Care Bureaucrats Elimination Act; S 2118, Health Care Bureaucrats Elimination Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Medicare/Medicaid MMM
Medicare rebates and Medicare Part D - Proposed legislation re this issue. Implementation of Patient Protection and Affordable Care Act - Executive Branch actions re this issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
Budget/Appropriations BUD
Fiscal cliff issues, prospects for tax reform and impact of budget negotiations on Medicare Part D funding - Congressional action re these issues; Executive Branch actions re these issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Consumer Issues/Safety/Products CSP
Supply chain issues (track and trace) - Proposed legislation re this issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.